Search
for
Sort by
Research 30 of 1000+
- Interferon alfa-2a in the treatment of cutaneous T cell lymphoma
- Concomitant Vitiligo and Psoriasis in a Patient Treated with Interferon Alfa‐2a for Chronic Hepatitis B Infection
- Dermatological Manifestations of Pegylated Interferon alfa2a and Ribavirin Combination Therapy in Chronic HCV Patients
- Hepatitis C Treatment and Alopecia Totalis
- Aldesleukin
- Cutaneous necrosis after injection of polyethylene glycol–modified interferon alfa
- Bullous Lesions at Polyethylene Glycol Interferon-alpha-2a Inoculation Site in a Hepatitis C Virus-infected Subject
- Interferon in the treatment of cutaneous T-cell lymphoma
- Reversible alopecia universalis secondary to PEG-interferon ??-2b and ribavirin combination therapy in a patient with chronic hepatitis C virus infection
- Resolution of advanced conjunctival squamous cell carcinoma with cemiplimab immunotherapy, IFNα-2b, and retinoic acid treatment over 2 years of follow-up
- Medication-induced hair loss: An update
- Reversible Alopecia Universalis During Treatment with PEG-Interferon and Ribavirin for Chronic Hepatitis C
- INTERFERONS IN DERMATOLOGY
- Irreversible alopecia universalis during treatment with pegylated interferon-ribavirin for chronic hepatitis C virus infection: Case report and published work review
- Alopecia universalis after discontinuation of pegylated interferon and ribavirin combination therapy for hepatitis C: a case report
- Lichen planus and other cutaneous manifestations in chronic hepatitis C: pre- and post-interferon-based treatment prevalence vary in a cohort of patients from low hepatitis C virus endemic area
- Pegylated-interferon-α<sub>2a</sub>in clinical practice: how to manage patients suffering from side effects
- Telogen Effluvium due to Recombinant Interferon α-2b
- Current management strategies for cutaneous T-cell lymphoma
- Cutaneous reactions to recombinant cytokine therapy
- Immunomodulators in the treatment of cutaneous lymphoma
- The efficacy and particular side effects of therapy peginterferon alpha-2a acute hepatitis C hemodialysed patients
- A Review of Adverse Cutaneous Drug Reactions Resulting from the Use of Interferon and Ribavirin
- Telogen effluvium related to post severe Sars‐Cov‐2 infection: Clinical aspects and our management experience
- Post-SARS-CoV-2 Acute Telogen Effluvium: An Expected Complication
- Cutaneous Reactions in Patients with Chronic Hepatitis C Treated with Peginterferon and Ribavirin
- Dermatología en la Práctica Médica General Vol. 13
- Farmácia da Cruz, Porto e Serviços Farmacêuticos do Hospital General Universitario Gregorio Marañón, Espanha
- Farmácia Lusitana, Vila do Conde e nos Serviços Farmacêuticos do Hospital CUF, Porto
- Hair loss after covid 19 - case series